ID   GLN1B_MYCTU             Reviewed;         478 AA.
AC   P9WN39; L0TAJ3; P0A590; Q10377;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   07-APR-2021, entry version 44.
DE   RecName: Full=Glutamine synthetase {ECO:0000303|PubMed:7937767};
DE            Short=GS {ECO:0000303|PubMed:7937767};
DE            EC=6.3.1.2 {ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:19695264};
DE   AltName: Full=Glutamate--ammonia ligase {ECO:0000305};
DE   AltName: Full=Glutamine synthetase I beta {ECO:0000305};
DE            Short=GSI beta {ECO:0000305};
GN   Name=glnA1 {ECO:0000303|PubMed:7937767}; Synonyms=glnA;
GN   OrderedLocusNames=Rv2220; ORFNames=MTCY190.31, MTCY427.01;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   STRAIN=ATCC 35801 / TMC 107 / Erdman;
RX   PubMed=9278431; DOI=10.1074/jbc.272.36.22728;
RA   Harth G., Horwitz M.A.;
RT   "Expression and efficient export of enzymatically active Mycobacterium
RT   tuberculosis glutamine synthetase in Mycobacterium smegmatis and evidence
RT   that the information for export is contained within the protein.";
RL   J. Biol. Chem. 272:22728-22735(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-21, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, ACTIVITY REGULATION, SUBSTRATE SPECIFICITY, AND SUBUNIT.
RC   STRAIN=ATCC 35801 / TMC 107 / Erdman;
RX   PubMed=7937767; DOI=10.1073/pnas.91.20.9342;
RA   Harth G., Clemens D.L., Horwitz M.A.;
RT   "Glutamine synthetase of Mycobacterium tuberculosis: extracellular release
RT   and characterization of its enzymatic activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:9342-9346(1994).
RN   [4]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=10618433; DOI=10.1073/pnas.97.1.418;
RA   Harth G., Zamecnik P.C., Tang J.Y., Tabatadze D., Horwitz M.A.;
RT   "Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to
RT   glutamine synthetase mRNA inhibits glutamine synthetase activity, formation
RT   of the poly-L-glutamate/glutamine cell wall structure, and bacterial
RT   replication.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:418-423(2000).
RN   [5]
RP   ACTIVITY REGULATION.
RX   PubMed=12496196; DOI=10.1128/iai.71.1.456-464.2003;
RA   Harth G., Horwitz M.A.;
RT   "Inhibition of Mycobacterium tuberculosis glutamine synthetase as a novel
RT   antibiotic strategy against tuberculosis: demonstration of efficacy in
RT   vivo.";
RL   Infect. Immun. 71:456-464(2003).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 35801 / TMC 107 / Erdman;
RX   PubMed=12819079; DOI=10.1128/iai.71.7.3927-3936.2003;
RA   Tullius M.V., Harth G., Horwitz M.A.;
RT   "Glutamine synthetase GlnA1 is essential for growth of Mycobacterium
RT   tuberculosis in human THP-1 macrophages and guinea pigs.";
RL   Infect. Immun. 71:3927-3936(2003).
RN   [7]
RP   AMPYLATION AT TYR-406, MUTAGENESIS OF TYR-406, AND ACTIVITY REGULATION.
RC   STRAIN=ATCC 27294 / TMC 102 / H37Rv;
RX   PubMed=15037612; DOI=10.1074/jbc.m401652200;
RA   Mehta R., Pearson J.T., Mahajan S., Nath A., Hickey M.J., Sherman D.R.,
RA   Atkins W.M.;
RT   "Adenylylation and catalytic properties of Mycobacterium tuberculosis
RT   glutamine synthetase expressed in Escherichia coli versus mycobacteria.";
RL   J. Biol. Chem. 279:22477-22482(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 2-478, ACTIVITY REGULATION,
RP   AMPYLATION AT TYR-406, AND SUBUNIT.
RX   PubMed=12146952; DOI=10.1021/bi020254s;
RA   Gill H.S., Pfluegl G.M., Eisenberg D.;
RT   "Multicopy crystallographic refinement of a relaxed glutamine synthetase
RT   from Mycobacterium tuberculosis highlights flexible loops in the enzymatic
RT   mechanism and its regulation.";
RL   Biochemistry 41:9863-9872(2002).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 2-478 IN COMPLEX WITH SUBSTRATE
RP   ANALOG; ATP ANALOG AND 2 MAGNESIUM IONS, AMPYLATION AT TYR-406, REACTION
RP   MECHANISM, COFACTOR, AND SUBUNIT.
RC   STRAIN=ATCC 35801 / TMC 107 / Erdman;
RX   PubMed=16027359; DOI=10.1073/pnas.0502248102;
RA   Krajewski W.W., Jones T.A., Mowbray S.L.;
RT   "Structure of Mycobacterium tuberculosis glutamine synthetase in complex
RT   with a transition-state mimic provides functional insights.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:10499-10504(2005).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-478 IN COMPLEX WITH SUBSTRATE
RP   ANALOG; ATP ANALOG AND 2 MAGNESIUM IONS, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, COFACTOR, AND SUBUNIT.
RX   PubMed=19695264; DOI=10.1016/j.jmb.2009.08.028;
RA   Nilsson M.T., Krajewski W.W., Yellagunda S., Prabhumurthy S.,
RA   Chamarahally G.N., Siddamadappa C., Srinivasa B.R., Yahiaoui S., Larhed M.,
RA   Karlen A., Jones T.A., Mowbray S.L.;
RT   "Structural basis for the inhibition of Mycobacterium tuberculosis
RT   glutamine synthetase by novel ATP-competitive inhibitors.";
RL   J. Mol. Biol. 393:504-513(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 2-478 IN COMPLEX WITH SUBSTRATE
RP   ANALOG; ATP ANALOG AND 2 MAGNESIUM IONS, COFACTOR, AND SUBUNIT.
RX   PubMed=22369127; DOI=10.1021/jm201212h;
RA   Gising J., Nilsson M.T., Odell L.R., Yahiaoui S., Lindh M., Iyer H.,
RA   Sinha A.M., Srinivasa B.R., Larhed M., Mowbray S.L., Karlen A.;
RT   "Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine
RT   synthetase inhibitors.";
RL   J. Med. Chem. 55:2894-2898(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 2-478 IN COMPLEX WITH SUBSTRATE
RP   ANALOG; ATP ANALOG AND 2 MAGNESIUM IONS, COFACTOR, AND SUBUNIT.
RX   DOI=10.1039/C2MD00310D;
RA   Nordqvist A., Nilsson M.T., Lagerlund O., Muthas D., Gising J.,
RA   Yahiaoui S., Odell L.R., Srinivasa B.R., Larhed M., Mowbray S.L.,
RA   Karlen A.;
RT   "Synthesis, biological evaluation and X-Ray crystallographic studies of
RT   imidazo(1,2-A)pyridine-based Mycobacterium tuberculosis glutamine
RT   synthetase inhibitors.";
RL   Med. Chem. Commun. 3:620-626(2012).
CC   -!- FUNCTION: Involved in nitrogen metabolism via ammonium assimilation.
CC       Catalyzes the ATP-dependent biosynthesis of glutamine from glutamate
CC       and ammonia (PubMed:7937767, PubMed:12819079). Also able to use GTP
CC       (PubMed:7937767). D-glutamate is a poor substrate, and DL-glutamate
CC       shows about 50% of the standard specific activity (PubMed:7937767).
CC       Also plays a key role in controlling the ammonia levels within infected
CC       host cells and so contributes to the pathogens capacity to inhibit
CC       phagosome acidification and phagosome-lysosome fusion (PubMed:7937767,
CC       PubMed:12819079). Involved in cell wall biosynthesis via the production
CC       of the major component poly-L-glutamine (PLG) (PubMed:7937767,
CC       PubMed:10618433). PLG synthesis in the cell wall occurs only in
CC       nitrogen limiting conditions and on the contrary high nitrogen
CC       conditions inhibit PLG synthesis (Probable).
CC       {ECO:0000269|PubMed:10618433, ECO:0000269|PubMed:12819079,
CC       ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:9278431}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-glutamate + NH4(+) = ADP + H(+) + L-glutamine +
CC         phosphate; Xref=Rhea:RHEA:16169, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58359, ChEBI:CHEBI:456216; EC=6.3.1.2;
CC         Evidence={ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:19695264};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:16027359, ECO:0000269|PubMed:19695264,
CC         ECO:0000269|PubMed:22369127, ECO:0000269|Ref.13};
CC       Note=Binds 2 Mg(2+) ions per subunit. {ECO:0000269|PubMed:16027359,
CC       ECO:0000269|PubMed:19695264, ECO:0000269|PubMed:22369127,
CC       ECO:0000269|Ref.13};
CC   -!- ACTIVITY REGULATION: When cellular nitrogen levels are high, the C-
CC       terminal adenylyl transferase (AT) of GlnE inhibits GlnA by covalent
CC       transfer of an adenylyl group from ATP to Tyr-406 (PubMed:15037612).
CC       Conversely, when nitrogen levels are low, the N-terminal adenylyl
CC       removase (AR) of GlnE activates GlnA by removing the adenylyl group by
CC       phosphorolysis (PubMed:15037612). The fully adenylated enzyme complex
CC       is inactive (Probable). Also inhibited by the diketopurine analog 1-
CC       [(3,4-dichlorophenyl)methyl]-3,7-dimethyl-8-morpholin-4-yl-purine-2,6-
CC       dione, EDTA, and by L-methionine-SR-sulfoximine (MSO) (PubMed:7937767,
CC       PubMed:12496196, PubMed:19695264). {ECO:0000269|PubMed:12496196,
CC       ECO:0000269|PubMed:15037612, ECO:0000269|PubMed:19695264,
CC       ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:12146952}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.5 mM for ATP {ECO:0000269|PubMed:19695264};
CC         KM=2.7 mM for L-glutamate {ECO:0000269|PubMed:7937767};
CC         KM=2.9 mM for L-glutamine {ECO:0000269|PubMed:7937767};
CC         KM=10.8 mM for ammonium {ECO:0000269|PubMed:19695264};
CC         KM=21.6 mM for L-glutamate {ECO:0000269|PubMed:19695264};
CC         Vmax=110 umol/min/mg enzyme {ECO:0000269|PubMed:7937767};
CC       pH dependence:
CC         Optimum pH is 7.5 in the presence of magnesium and cobalt ions
CC         (PubMed:7937767, PubMed:19695264). Optimum pH is 7 in the presence of
CC         manganese ions (PubMed:7937767). {ECO:0000269|PubMed:19695264,
CC         ECO:0000269|PubMed:7937767};
CC   -!- SUBUNIT: Oligomer of 12 subunits arranged in the form of two hexagons.
CC       {ECO:0000269|PubMed:12146952, ECO:0000269|PubMed:16027359,
CC       ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:19695264,
CC       ECO:0000305|PubMed:22369127, ECO:0000305|Ref.13}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305|PubMed:9278431}.
CC   -!- INDUCTION: Repressed by phosphorothioate modified antisense
CC       oligodeoxyribonucleotides (PS-ODNs), which acts against the mRNA of
CC       glutamine synthetase. {ECO:0000269|PubMed:10618433}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene do not show a detectable
CC       glutamine synthetase activity and is auxotrophic for L-glutamine. This
CC       mutant is also attenuated for intracellular growth in human THP-1
CC       macrophages and avirulent in the highly susceptible guinea pig model of
CC       pulmonary tuberculosis. {ECO:0000269|PubMed:12819079}.
CC   -!- SIMILARITY: Belongs to the glutamine synthetase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U87280; AAB70038.1; -; Genomic_DNA.
DR   EMBL; AL123456; CCP44998.1; -; Genomic_DNA.
DR   PIR; H70775; H70775.
DR   RefSeq; NP_216736.1; NC_000962.3.
DR   RefSeq; WP_003411475.1; NZ_NVQJ01000008.1.
DR   PDB; 1HTO; X-ray; 2.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=2-478.
DR   PDB; 1HTQ; X-ray; 2.40 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=2-478.
DR   PDB; 2BVC; X-ray; 2.10 A; A/B/C/D/E/F=2-478.
DR   PDB; 2WGS; X-ray; 2.55 A; A/B/C/D/E/F/G/H/I/J/K/L=2-478.
DR   PDB; 2WHI; X-ray; 2.20 A; A/B/C/D/E/F=2-478.
DR   PDB; 3ZXR; X-ray; 2.15 A; A/B/C/D/E/F=2-478.
DR   PDB; 3ZXV; X-ray; 2.26 A; A/B/C/D/E/F=2-478.
DR   PDB; 4ACF; X-ray; 2.00 A; A/B/C/D/E/F=2-478.
DR   PDB; 4XYC; X-ray; 3.30 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T/U/V/W/X=1-478.
DR   PDBsum; 1HTO; -.
DR   PDBsum; 1HTQ; -.
DR   PDBsum; 2BVC; -.
DR   PDBsum; 2WGS; -.
DR   PDBsum; 2WHI; -.
DR   PDBsum; 3ZXR; -.
DR   PDBsum; 3ZXV; -.
DR   PDBsum; 4ACF; -.
DR   PDBsum; 4XYC; -.
DR   SMR; P9WN39; -.
DR   STRING; 83332.Rv2220; -.
DR   DrugBank; DB04272; Citric acid.
DR   PaxDb; P9WN39; -.
DR   GeneID; 45426197; -.
DR   GeneID; 888383; -.
DR   KEGG; mtu:Rv2220; -.
DR   TubercuList; Rv2220; -.
DR   eggNOG; COG0174; Bacteria.
DR   OMA; PHPHEFE; -.
DR   PhylomeDB; P9WN39; -.
DR   PHI-base; PHI:7587; -.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005618; C:cell wall; HDA:MTBBASE.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; HDA:MTBBASE.
DR   GO; GO:0005576; C:extracellular region; IDA:CAFA.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; HDA:MTBBASE.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0001968; F:fibronectin binding; IPI:CAFA.
DR   GO; GO:0004356; F:glutamate-ammonia ligase activity; IDA:MTBBASE.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035375; F:zymogen binding; IPI:CAFA.
DR   GO; GO:0006542; P:glutamine biosynthetic process; IMP:MTBBASE.
DR   GO; GO:0019740; P:nitrogen utilization; IBA:GO_Central.
DR   GO; GO:0009405; P:pathogenesis; IMP:MTBBASE.
DR   GO; GO:0010756; P:positive regulation of plasminogen activation; IDA:CAFA.
DR   Gene3D; 3.10.20.70; -; 1.
DR   InterPro; IPR008147; Gln_synt_b-grasp.
DR   InterPro; IPR036651; Gln_synt_N.
DR   InterPro; IPR014746; Gln_synth/guanido_kin_cat_dom.
DR   InterPro; IPR008146; Gln_synth_cat_dom.
DR   InterPro; IPR027303; Gln_synth_gly_rich_site.
DR   InterPro; IPR004809; Gln_synth_I.
DR   InterPro; IPR001637; Gln_synth_I_adenylation_site.
DR   InterPro; IPR027302; Gln_synth_N_conserv_site.
DR   Pfam; PF00120; Gln-synt_C; 1.
DR   Pfam; PF03951; Gln-synt_N; 1.
DR   SMART; SM01230; Gln-synt_C; 1.
DR   SUPFAM; SSF54368; SSF54368; 1.
DR   SUPFAM; SSF55931; SSF55931; 1.
DR   TIGRFAMs; TIGR00653; GlnA; 1.
DR   PROSITE; PS00180; GLNA_1; 1.
DR   PROSITE; PS00182; GLNA_ADENYLATION; 1.
DR   PROSITE; PS00181; GLNA_ATP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Cytoplasm; Direct protein sequencing; Ligase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Virulence.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:7937767"
FT   CHAIN           2..478
FT                   /note="Glutamine synthetase"
FT                   /id="PRO_0000153246"
FT   NP_BIND         230..232
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0007744|PDB:2BVC"
FT   NP_BIND         278..280
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0000305|PubMed:19695264, ECO:0000305|PubMed:22369127,
FT                   ECO:0000305|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   REGION          271..272
FT                   /note="L-glutamate binding"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0000305|PubMed:19695264, ECO:0000305|PubMed:22369127,
FT                   ECO:0000305|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   METAL           133
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000269|PubMed:16027359,
FT                   ECO:0000269|PubMed:19695264, ECO:0000269|PubMed:22369127,
FT                   ECO:0000269|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   METAL           135
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000269|PubMed:16027359,
FT                   ECO:0000269|PubMed:19695264, ECO:0000269|PubMed:22369127,
FT                   ECO:0000269|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   METAL           219
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000269|PubMed:16027359,
FT                   ECO:0000269|PubMed:19695264, ECO:0000269|PubMed:22369127,
FT                   ECO:0000269|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   METAL           227
FT                   /note="Magnesium 2"
FT                   /evidence="ECO:0000269|PubMed:16027359,
FT                   ECO:0000269|PubMed:19695264, ECO:0000269|PubMed:22369127,
FT                   ECO:0000269|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   METAL           276
FT                   /note="Magnesium 1; via pros nitrogen"
FT                   /evidence="ECO:0000269|PubMed:16027359,
FT                   ECO:0000269|PubMed:19695264, ECO:0000269|PubMed:22369127,
FT                   ECO:0000269|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   METAL           366
FT                   /note="Magnesium 1"
FT                   /evidence="ECO:0000269|PubMed:16027359,
FT                   ECO:0000269|PubMed:19695264, ECO:0000269|PubMed:22369127,
FT                   ECO:0000269|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   BINDING         214
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0007744|PDB:2BVC"
FT   BINDING         272
FT                   /note="L-glutamate; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:P12425"
FT   BINDING         280
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P77961"
FT   BINDING         329
FT                   /note="L-glutamate"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0000305|PubMed:19695264, ECO:0000305|PubMed:22369127,
FT                   ECO:0000305|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   BINDING         335
FT                   /note="L-glutamate"
FT                   /evidence="ECO:0000250|UniProtKB:P0A1P6"
FT   BINDING         347
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:19695264,
FT                   ECO:0000305|PubMed:22369127, ECO:0007744|PDB:2WHI,
FT                   ECO:0007744|PDB:3ZXR"
FT   BINDING         347
FT                   /note="L-glutamate"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0000305|PubMed:19695264, ECO:0000305|PubMed:22369127,
FT                   ECO:0000305|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   BINDING         352
FT                   /note="ATP"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0000305|PubMed:22369127, ECO:0000305|Ref.13,
FT                   ECO:0007744|PDB:2BVC, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   BINDING         361
FT                   /note="ATP"
FT                   /evidence="ECO:0000250|UniProtKB:P77961"
FT   BINDING         368
FT                   /note="L-glutamate"
FT                   /evidence="ECO:0000305|PubMed:16027359,
FT                   ECO:0000305|PubMed:19695264, ECO:0000305|PubMed:22369127,
FT                   ECO:0000305|Ref.13, ECO:0007744|PDB:2BVC,
FT                   ECO:0007744|PDB:2WHI, ECO:0007744|PDB:3ZXR,
FT                   ECO:0007744|PDB:3ZXV, ECO:0007744|PDB:4ACF"
FT   MOD_RES         406
FT                   /note="O-AMP-tyrosine"
FT                   /evidence="ECO:0000269|PubMed:15037612,
FT                   ECO:0000305|PubMed:12146952, ECO:0000305|PubMed:16027359"
FT   MUTAGEN         406
FT                   /note="Y->F: Unable to be adenylylated."
FT                   /evidence="ECO:0000269|PubMed:15037612"
FT   HELIX           6..15
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          20..26
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          28..30
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          32..38
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           39..41
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           44..48
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          51..54
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           55..57
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          58..62
FT                   /evidence="ECO:0007744|PDB:1HTQ"
FT   HELIX           64..66
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          68..73
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           75..77
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          88..96
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   TURN            98..100
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           108..122
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          126..134
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          136..146
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          151..156
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           161..163
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          186..188
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   TURN            190..192
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           196..208
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          213..218
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   TURN            222..224
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          225..230
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           235..255
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          259..261
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          275..283
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          286..290
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           295..297
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           300..320
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           326..329
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          330..333
FT                   /evidence="ECO:0007744|PDB:1HTQ"
FT   STRAND          334..336
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          338..340
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          342..344
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          349..353
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   TURN            360..362
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          365..367
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   STRAND          372..374
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           376..392
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           405..407
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           410..414
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           423..432
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           435..438
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           439..441
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           445..458
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           460..464
FT                   /evidence="ECO:0007744|PDB:4ACF"
FT   HELIX           469..475
FT                   /evidence="ECO:0007744|PDB:4ACF"
SQ   SEQUENCE   478 AA;  53570 MW;  576E30073484136D CRC64;
     MTEKTPDDVF KLAKDEKVEY VDVRFCDLPG IMQHFTIPAS AFDKSVFDDG LAFDGSSIRG
     FQSIHESDML LLPDPETARI DPFRAAKTLN INFFVHDPFT LEPYSRDPRN IARKAENYLI
     STGIADTAYF GAEAEFYIFD SVSFDSRANG SFYEVDAISG WWNTGAATEA DGSPNRGYKV
     RHKGGYFPVA PNDQYVDLRD KMLTNLINSG FILEKGHHEV GSGGQAEINY QFNSLLHAAD
     DMQLYKYIIK NTAWQNGKTV TFMPKPLFGD NGSGMHCHQS LWKDGAPLMY DETGYAGLSD
     TARHYIGGLL HHAPSLLAFT NPTVNSYKRL VPGYEAPINL VYSQRNRSAC VRIPITGSNP
     KAKRLEFRSP DSSGNPYLAF SAMLMAGLDG IKNKIEPQAP VDKDLYELPP EEAASIPQTP
     TQLSDVIDRL EADHEYLTEG GVFTNDLIET WISFKRENEI EPVNIRPHPY EFALYYDV
//
